Filing Flows › Comparisons › ARQT vs IRWD
Arcutis Biotherapeutics vs Ironwood Pharmaceuticals: ARQT and IRWD compared
Arcutis Biotherapeutics is the larger company: $144M of revenue in its latest quarter (Q3 2026) against $133M for Ironwood Pharmaceuticals (Q3 2026). Arcutis Biotherapeutics is growing faster (+45% against +9% a year earlier). Ironwood Pharmaceuticals is more profitable, with an operating margin of 70.0% against 6.6%.
Where the money goes: ARQT and IRWD
Arcutis Biotherapeutics (ARQT) · Q3 2026
Arcutis Biotherapeutics, Q3 2026: revenue $144M (+45% year over year), operating margin 6.6%, net earnings $8.8M, operating cash flow $18.9M. The chart follows the revenue to costs, profit and cash.
Ironwood Pharmaceuticals (IRWD) · Q3 2026
Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.
| Arcutis Biotherapeutics (ARQT) | Ironwood Pharmaceuticals (IRWD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $144M | $133M |
| Revenue growth, Y/Y | +45% | +9% |
| Operating margin | 6.6% | 70.0% |
| Net earnings | $8.8M | $59.8M |
| Net margin | 6.1% | 45.0% |
| Operating cash flow | $18.9M | $67.4M |
| Free cash flow | $18.8M | — |
Where the revenue comes from
Arcutis Biotherapeutics
- ZORYVE foam: $75.1M (52%)
- ZORYVE cream 0.3%: $37.8M (26%)
- ZORYVE cream 0.15%: $27.3M (19%)
- ZORYVE cream 0.05%: $3.7M (3%)
Questions
Which is bigger, Arcutis Biotherapeutics or Ironwood Pharmaceuticals?
Arcutis Biotherapeutics is the larger company: $144M of revenue in its latest quarter (Q3 2026) against $133M for Ironwood Pharmaceuticals (Q3 2026).
Is Arcutis Biotherapeutics or Ironwood Pharmaceuticals growing faster?
Arcutis Biotherapeutics is growing faster (+45% against +9% a year earlier).
Which is more profitable, Arcutis Biotherapeutics or Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals is more profitable, with an operating margin of 70.0% against 6.6%.
More: Arcutis Biotherapeutics earnings · how Arcutis Biotherapeutics makes money · Ironwood Pharmaceuticals earnings · how Ironwood Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.